Related Experiment Video
Updated: Jul 15, 2025

08:48
Author Spotlight: Exploring the Complexities of Achilles Tendon Injuries — Research and Future Directions
Published on: October 27, 2023
785
Midterm Outcomes of Operatively and Nonoperatively Managed Achilles Tendon Ruptures in Young Adults
Laurence Ge1, Noah Saunders2, Dakota Betts1
1Department of Orthopedic Surgery, University of Michigan, Ann Arbor, MI, USA.
Foot & Ankle Orthopaedics
|September 28, 2023
Summary
Young adults with Achilles tendon ruptures (ATR) can be treated operatively or nonoperatively with similar outcomes. This study found no significant differences in deep venous thrombosis (DVT), rerupture rates, or patient-reported function between the two management strategies.
Area of Science:
- Orthopedic Surgery
- Sports Medicine
- Musculoskeletal Research
Background:
- Controversy exists regarding optimal treatment for Achilles tendon ruptures (ATR).
- Young adults (18-30 years) represent a distinct demographic for ATR management.
- Previous studies have not specifically evaluated outcomes in this age group.
Purpose of the Study:
- To compare outcomes of operative versus nonoperative management for acute Achilles tendon ruptures in young adults.
- To evaluate differences in deep venous thrombosis (DVT) and rerupture rates.
- To assess patient-reported physical function and pain interference using PROMIS scores.
Main Methods:
- Retrospective cohort study of patients aged 18-30 years with acute ATR.
- Data collected included demographics, BMI, smoking status, CCI, DVT, and rerupture rates.
- PROMIS physical function (PF) and pain interference (PI) questionnaires were administered.
Main Results:
- Operative (n=28) and nonoperative (n=14) cohorts showed no significant differences in age, BMI, DVT rates (6.1% vs 5.4%), or rerupture rates (3.0% vs 2.7%).
- PROMIS PF scores were similar (mean 60.4 vs 62.9, P=.33).
- PROMIS PI scores were also similar (mean 44.6 vs 43.9, P=.59).
Conclusions:
- Young adults with ATR can be considered for either operative or nonoperative management.
- No significant differences were observed in DVT rates, rerupture rates, or PROMIS scores between the two treatment groups.
- Findings should be interpreted considering the study's significant loss to follow-up rate.

